["{\"step_by_step_thinking\": \"There is no mention of tivantinib or MET-high hepatocellular carcinoma in the provided documents. The documents discuss various antineoplastic agents, but none specifically address tivantinib and hepatocellular carcinoma. Therefore, we cannot conclude whether tivantinib is effective for MET-high hepatocellular carcinoma based on these documents.\", \"answer_choice\": \"B\"}"]